ENOV Stock and Options Trade Setup — Enovis Corporation
S&P MidCap 400 · Medical Devices (Orthopedics & Reconstruction) · Low options liquidity · Mid cap · ~$3.8B
Enovis is building a compelling orthopedic reconstruction platform through the LimaCorporate and Mathys acquisitions, adding hip and knee implant capabilities that compete directly with Stryker and Zimmer Biomet at a fraction of the market cap. The aging demographics of the Baby Boomer cohort are driving a structural multi-decade increase in joint replacement procedures, and Enovis is growing procedure volumes faster than the market through surgeon training and robotic-assisted surgical system adoption. The prevention & recovery segment (DJO bracing and cold therapy) provides a direct retail channel that cross-sells to the same orthopedic patient population. Management has articulated a clear path to 20%+ EBITDA margins by 2028, implying significant earnings-per-share expansion from the current depressed base.
Score History & Signal Changelog
Preview dataThis page is a living document — updated every 72 hours from the last scan. Each data point below represents one complete algorithmic snapshot.
Signal Breakdown
Today's Trade Card
Options Profile
Risks & Fundamentals
Every setup carries risk. Here's what could move ENOV against you, plus the key stats that frame any position.
- 1.Integration complexity across multiple international acquisitions (Lima, Mathys) straining operational execution
- 2.Hospital elective procedure volumes remaining below trend if health system staffing shortages persist
- 3.Pricing pressure from GPO (group purchasing organisation) contracting reducing implant average selling prices
ENOV Options Setup — Frequently Asked Questions
Is ENOV a good options trade today?+
Enovis Corporation (ENOV) currently has an Amora Edge Score of 63/100, ranking it top 30% of today's scan. This composite score is built from four sub-signals — EMA cross, RSI zone, relative strength vs SPY, and volume surge — each scored 0–25. The current read is a bullish setup, so the algorithm is positioned bullish (calls / call debit spreads). A score above 65 typically warrants a trade card with stop and target; below that, the setup is on the watchlist but not actionable.
What is ENOV's win rate on Stoptions.ai setups?+
ENOV's historical win rate on closed Stoptions setups is 60%. Win rate is calculated as the percentage of past ENOV trade cards that hit their target price before stopping out. Win rate is most meaningful once a ticker has 10+ closed trades — individual ticker rates can be noisy at smaller samples. Our portfolio-wide win rate across all closed trades is the more stable benchmark.
What strike and expiry does Stoptions.ai suggest for ENOV?+
The strike and expiry are shown on the trade card at the top of this page when the setup is active. Stoptions.ai algorithmically selects strikes targeting delta 0.35–0.45 and expirations 30–45 days out, adjusted for current implied volatility rank (IVR). When IVR is high, the system favors call debit spreads to limit vega risk; when IVR is low, single-leg long calls are preferred. The card includes the contract symbol, mid-price entry, stop, and target.
How often is the ENOV setup updated?+
Every 72 hours we refresh ENOV's Amora Edge Score and trade card. The underlying scan runs daily at 9:00 AM ET (pre-market) and 9:30 AM ET (post-open), so any new signal change is reflected within one trading session. If ENOV drops below the entry threshold or the regime shifts (e.g., SPY enters a confirmed bear), the trade card is replaced with a "no setup" notice automatically.
What does the Amora Edge Score measure for ENOV?+
The Amora Edge Score is a 0–100 composite of four technical sub-signals applied to ENOV: (1) EMA cross — is the 20-day above the 50-day with both trending up? (2) RSI zone — is momentum in the 50–70 sweet spot, or extended/weak? (3) Relative strength vs SPY — is ENOV outperforming the market over 20 sessions? (4) Volume surge — is participation above the 20-day average? Each sub-signal contributes 0–25 points. ENOV currently scores 63.
How does ENOV compare to other Medical Devices (Orthopedics & Reconstruction) setups?+
ENOV's sector rank and percentile against other Medical Devices (Orthopedics & Reconstruction) tickers we track is shown on the /tickers index — sortable by Amora Edge Score, win rate, or sector. For direct comparison, see the "Related Medical Devices (Orthopedics & Reconstruction) Options Setups" panel above. When multiple tickers in the same sector are scoring 80+, the algorithm flags the cluster as a sector rotation signal and may upweight position sizing.
Educational content only — not personalized investment advice. Options carry substantial risk.
Get a Friday recap including setups like ENOV.
Every Friday at 4:30 PM ET — trade of the week, signals in motion, sector spotlight, methodology read. 4-minute read. Free.
No spam. One email Friday afternoon. Unsubscribe in one click.